Therapeutic Areas

Expertise Areas

Emmes’ expertise covers a broad range of therapeutic areas with a particular focus on Vaccines and Infectious Diseases, Ophthalmology, Neuroscience, Cell and Gene Therapy, and Rare Disease. With a rich history of scientific inquiry, deep networks in site, investigator, and patient communities, and a strong commitment to delivering outcomes for our clients, Emmes is your full-service CRO partner for your clinical trials.

We are also advancing our legacy of scientific excellence by optimizing all aspects of clinical trials to deliver programs faster and more efficiently through the end-to-end use of technology and AI. A powerful combination delivering the clinical research infrastructure of the 21st century.

Therapeutic Area Experience

Please click the links below to view profiles of clinical research we’ve conducted across therapy areas.

Therapeutic Area Experience Graphic
Vaccines and Infectious Diseases

Vaccines and Infectious Diseases

As a full service CRO, Emmes has worked on nearly every epidemic and pandemic since our founding in 1977, including HIV-AIDs, Zika Virus, Ebola, SARS, MERS, H1N1, and COVID-19.

Learn More

Ophthalmology

Ophthalmology

Clients seek Emmes’ Ophthalmology clinical research services for a variety of disorders including age-related macular degeneration, glaucoma, diabetic retinopathy, and rare diseases.

Learn More

Neuroscience

Neuroscience

Clients leverage a broad range of expertise in neurological and psychiatric disorders possessed by our neuroscience therapeutic research unit. We have significant experience in traumatic brain injury, stroke, epilepsy, autism, depression, schizophrenia and substance use disorders.

Learn More

Cell and Gene Therapy

Cell and Gene Therapy

We’ve proven our expertise over 45 years, driving more than 125 clinical studies and advancing gene or cell therapies in a range of therapeutic areas with comprehensive clinical trial services. How can we help you to unlock real potential and create life-changing treatments?

Learn More

Rare Disease

Rare Disease

Clinical research on rare diseases has proliferated since the passage of the Orphan Drug Act in 1983. Emmes has helped clients conduct rare disease research across several therapeutic areas including infectious diseases, ophthalmology, oncology, autoimmune, neurology, and hematology.

Learn More

Schedule a Meeting

To speak with one of our therapeutic area experts about your trial or plans, please contact us.

We welcome your inquiries and will respond promptly.